Alopecia universalis during treatment with leflunomide and adalimumab - Case report
AUTOR(ES)
Lazzarini, Rosana, Capareli, Gabriela Cunha, Buense, Roberta, Lellis, Rute Facchini
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2014-04
RESUMO
Alopecia areata is a non-scarring form of alopecia that can be localized or widespread. Its etiology is unknown, but immunological factors are implicated in its pathogenesis. With the more frequent use of anti TNFα biologic drugs, some alopecia areata cases during their use have been described. We report a case of universal alopecia in a patient with rheumatoid arthritis while using adalimumab and leflunomide.
Documentos Relacionados
- Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis
- Trichotillomania: a case report with clinical and dermatoscopic differential diagnosis with alopecia areata
- Alopecia universalis in autoimmune polyglandular syndrome type I.
- Dapsone syndrome with acute renal failure during leprosy treatment: case report
- Alopecia universalis as a feature of polyglandular autoimmunity type I.